DC Judge Calls Teva's Bid To Reclassify Drug Anticompetitive
A D.C. federal court has shot down Teva Pharmaceutical's lawsuit against the U.S. Food and Drug Administration and the Department of Health and Human Services to get its multiple sclerosis drug...To view the full article, register now.
Already a subscriber? Click here to view full article